Your browser doesn't support javascript.
loading
Impact of alirocumab/evolocumab on lipoprotein (a) concentrations in patients with familial hypercholesterolaemia: a systematic review and meta-analysis of randomized controlled trials.
Dai, Haibing; Zhu, Yonglin; Chen, Zuyi; Yan, Renqing; Liu, Jinsong; He, Ziyun; Zhang, Lin; Zhang, Feng; Yan, Shengkai.
Afiliação
  • Dai H; Department of Laboratory Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, China. 2832845671@qq.com.
  • Zhu Y; College of Laboratory Medicine, Zunyi Medical University, Zunyi, China. 2832845671@qq.com.
  • Chen Z; Department of Laboratory Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
  • Yan R; College of Laboratory Medicine, Zunyi Medical University, Zunyi, China.
  • Liu J; Department of Laboratory Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
  • He Z; College of Laboratory Medicine, Zunyi Medical University, Zunyi, China.
  • Zhang L; Department of Laboratory Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
  • Zhang F; College of Laboratory Medicine, Zunyi Medical University, Zunyi, China.
  • Yan S; Department of Laboratory Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Endokrynol Pol ; 74(3): 234-242, 2023.
Article em En | MEDLINE | ID: mdl-37335067
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hiperlipoproteinemia Tipo II / Anticolesterolemiantes Tipo de estudo: Clinical_trials / Etiology_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Endokrynol Pol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hiperlipoproteinemia Tipo II / Anticolesterolemiantes Tipo de estudo: Clinical_trials / Etiology_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Endokrynol Pol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China